| Clarendon Nursing Home | |
| Ten Medical Center Dr, Clarendon, Texas 79226 | |
| (806) 874-2273 | |
| Name | Clarendon Nursing Home |
|---|---|
| Location | Ten Medical Center Dr, Clarendon, Texas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 61 |
| Occupancy Rate | 83.77% |
| Medicare ID (CCN) | 676411 |
| Legal Business Name | Clarendon Nh Operations |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1275947178 |
| Organization Name | CHILDRESS COUNTY HOSPITAL DISTRICT |
| Doing Business As | CLARENDON RESIDENCE AND REHABILITATION CENTER |
| Address | Ten Medical Center Drive, Clarendon, TX 79226 |
| Phone Number | 806-874-5221 |
News Archive
According to a new survey by Donate Life America, 43 percent of people are undecided, reluctant or do not wish to have their organs and tissue donated after their deaths. While an improvement over findings from a similar survey last year in which 50 percent reported the same, the statistic illustrates a critical need to continue to increase the level of support for organ donation to save the lives of the more than 105,000 adults and children on the transplant waiting list in the U.S., an average 18 of whom die each day waiting.
Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, today celebrates ten years of continuous growth.
Receiving palliative or hospice care services was found to improve quality of life for hospitalized ischemic stroke patients, however, disparities persist in which patients are prescribed or have access to these holistic comfort care options, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Crospon has today announced that it has received FDA clearance for its EsoFLIP balloon dilation catheter. This is the first product the in what will be a suite of dilation catheter products to be used for dilation procedures in the esophagus and colon. It represents the company's first foray into the therapeutic endoscopy accessory market.
Hemispherx Biopharma, Inc. today announced that its six-year litigation battle with the South African investment conglomerate JCI Ltd., traded on the Johannesburg Stock Exchange, ended in victory August 11, 2010, with the entry of a $188 million judgment in Hemispherx's favor and against Johannesburg Consolidated Investments (JCI) and former JCI officers R.B. Kebble and H.C. Buitendag.
› Verified 4 days ago
| NPI Number | 1447619663 |
| Organization Name | CLARENDON NH OPERATIONS |
| Doing Business As | CLARENDON NURSING HOME |
| Address | Ten Medical Center Drive, Clarendon, TX 79226 |
| Phone Number | 937-459-2297 |
News Archive
According to a new survey by Donate Life America, 43 percent of people are undecided, reluctant or do not wish to have their organs and tissue donated after their deaths. While an improvement over findings from a similar survey last year in which 50 percent reported the same, the statistic illustrates a critical need to continue to increase the level of support for organ donation to save the lives of the more than 105,000 adults and children on the transplant waiting list in the U.S., an average 18 of whom die each day waiting.
Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, today celebrates ten years of continuous growth.
Receiving palliative or hospice care services was found to improve quality of life for hospitalized ischemic stroke patients, however, disparities persist in which patients are prescribed or have access to these holistic comfort care options, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Crospon has today announced that it has received FDA clearance for its EsoFLIP balloon dilation catheter. This is the first product the in what will be a suite of dilation catheter products to be used for dilation procedures in the esophagus and colon. It represents the company's first foray into the therapeutic endoscopy accessory market.
Hemispherx Biopharma, Inc. today announced that its six-year litigation battle with the South African investment conglomerate JCI Ltd., traded on the Johannesburg Stock Exchange, ended in victory August 11, 2010, with the entry of a $188 million judgment in Hemispherx's favor and against Johannesburg Consolidated Investments (JCI) and former JCI officers R.B. Kebble and H.C. Buitendag.
› Verified 4 days ago
| NPI Number | 1578732939 |
| Organization Name | CLARENDON SKILLED CARE LTD |
| Doing Business As | COMMUNITY CARE CENTER OF CLARENDON |
| Address | Ten Medical Center Drive, Clarendon, TX 79226 |
| Phone Number | 806-874-5221 |
News Archive
According to a new survey by Donate Life America, 43 percent of people are undecided, reluctant or do not wish to have their organs and tissue donated after their deaths. While an improvement over findings from a similar survey last year in which 50 percent reported the same, the statistic illustrates a critical need to continue to increase the level of support for organ donation to save the lives of the more than 105,000 adults and children on the transplant waiting list in the U.S., an average 18 of whom die each day waiting.
Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, today celebrates ten years of continuous growth.
Receiving palliative or hospice care services was found to improve quality of life for hospitalized ischemic stroke patients, however, disparities persist in which patients are prescribed or have access to these holistic comfort care options, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Crospon has today announced that it has received FDA clearance for its EsoFLIP balloon dilation catheter. This is the first product the in what will be a suite of dilation catheter products to be used for dilation procedures in the esophagus and colon. It represents the company's first foray into the therapeutic endoscopy accessory market.
Hemispherx Biopharma, Inc. today announced that its six-year litigation battle with the South African investment conglomerate JCI Ltd., traded on the Johannesburg Stock Exchange, ended in victory August 11, 2010, with the entry of a $188 million judgment in Hemispherx's favor and against Johannesburg Consolidated Investments (JCI) and former JCI officers R.B. Kebble and H.C. Buitendag.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
According to a new survey by Donate Life America, 43 percent of people are undecided, reluctant or do not wish to have their organs and tissue donated after their deaths. While an improvement over findings from a similar survey last year in which 50 percent reported the same, the statistic illustrates a critical need to continue to increase the level of support for organ donation to save the lives of the more than 105,000 adults and children on the transplant waiting list in the U.S., an average 18 of whom die each day waiting.
Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, today celebrates ten years of continuous growth.
Receiving palliative or hospice care services was found to improve quality of life for hospitalized ischemic stroke patients, however, disparities persist in which patients are prescribed or have access to these holistic comfort care options, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.
Crospon has today announced that it has received FDA clearance for its EsoFLIP balloon dilation catheter. This is the first product the in what will be a suite of dilation catheter products to be used for dilation procedures in the esophagus and colon. It represents the company's first foray into the therapeutic endoscopy accessory market.
Hemispherx Biopharma, Inc. today announced that its six-year litigation battle with the South African investment conglomerate JCI Ltd., traded on the Johannesburg Stock Exchange, ended in victory August 11, 2010, with the entry of a $188 million judgment in Hemispherx's favor and against Johannesburg Consolidated Investments (JCI) and former JCI officers R.B. Kebble and H.C. Buitendag.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $21580 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.5 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.71 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 44.59 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.51 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.76 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 67.15 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 30.16 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 26.09 | 83.88 |